2026-06-26T15:32:11Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/120592024-04-16T18:08:11Zcom_20.500.14352_14col_20.500.14352_15

Martínez Carmona, Marina Gun´ko, Yurii Vallet Regí, María Dulce Nombre 2023-06-17T12:26:56Z 2023-06-17T12:26:56Z 2018-04-23 2079-4991 10.3390/nano8040268 https://hdl.handle.net/20.500.14352/12059 http://www.mdpi.com/2079-4991/8/4/268 http://www.ucm.es/valletregigroup In the last two decades, zinc oxide (ZnO) semiconductor Quantum dots (QDs) have been shown to have fantastic luminescent properties, which together with their low-cost, low-toxicity and biocompatibility have turned these nanomaterials into one of the main candidates for bio-imaging. The discovery of other desirable traits such as their ability to produce destructive reactive oxygen species (ROS), high catalytic efficiency, strong adsorption capability and high isoelectric point, also make them promising nanomaterials for therapeutic and diagnostic functions. Herein, we review the recent progress on the use of ZnO based nanoplatforms in drug delivery and theranostic in several diseases such as bacterial infection and cancer. eng https://creativecommons.org/licenses/by/3.0/es/ open access Atribución 3.0 España ZnO Nanostructures for Drug Delivery and Theranostic Applications journal article